Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy (Q40811095)

23 September 2017

1 reference

title

Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy (English)

1 reference

23 September 2017

0 references

Eberhardt RT

1

1 reference

23 September 2017

Kevak RM

series ordinal

2

1 reference

23 September 2017

Kang PM

series ordinal

3

1 reference

23 September 2017

Frishman WH

series ordinal

4

1 reference

23 September 2017

1 November 1993

1 reference

The Journal of Clinical Pharmacology

23 September 2017

1 reference

23 September 2017

33

1 reference

23 September 2017

1023-1038

1 reference

23 September 2017

11

1 reference

Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease

23 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Functions of angiotensin in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Circulating and tissue angiotensin systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Mechanism for the postive inotropic effect of angiotensin II on isolated cardiac muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Identification of angiotensin II receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Regional distribution of the two subtypes of angiotensin II receptor in rat brain using selective nonpeptide antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Effect of blocking angiotensin II receptor subtype on rat sympathetic nerve function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Effect of angiotensin II antagonism on canine renal sympathetic nerve function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Proximal nephron and renal effects of DuP 753, a nonpeptide angiotensin II receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Cloning and characterization of a human angiotensin II type 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Angiotensin II type-1 receptor subtype cDNAs: differential tissue expression and hormonal regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Angiotensin II receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Use of an Angiotensin II Antagonist (Saralasin) in the Recognition of “Angiotensinogenic” Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Pressor response to saralasin (1-sar-8-ala-angiotensin II) bolus injection in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Nonpeptide angiotensin II receptor antagonists. IV. EXP6155 and EXP6803.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Nonpeptide angiotensin II receptor antagonists. Studies with EXP9270 and DuP 753.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

DuP 753 is a specific antagonist for the angiotensin receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Further studies on the selectivity of DuP 753, a nonpeptide angiotensin II receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Differential regional haemodynamic effects of the non-peptide angiotensin II antagonist, DuP 753, in water-replete and water-deprived Brattleboro rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Cardiac haemodynamic effects of the non-peptide, angiotensin II-receptor antagonist, DuP 753, in conscious Long Evans and Brattleboro rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Neurohumoral control mechanisms in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB01939.X

10.1002/J.1552-4604.1993.TB01939.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference